6316-67-2 Usage
Uses
Used in Pharmaceutical Industry:
3-Pyridinecarboxylic acid, 4-methyl, hydrazide (9CI) is used as an intermediate in the synthesis of pharmaceuticals for its potential antifungal, antitubercular, and cytotoxic properties.
Used in Agrochemical Industry:
3-Pyridinecarboxylic acid, 4-methyl, hydrazide (9CI) is used as an intermediate in the synthesis of agrochemicals for its potential application in the development of antifungal and antitubercular agents.
Used in Metal Chelate Production:
3-Pyridinecarboxylic acid, 4-methyl, hydrazide (9CI) is used in the production of metal chelates, which are important in various chemical and industrial applications.
Used in Organic Compound Preparation:
3-Pyridinecarboxylic acid, 4-methyl, hydrazide (9CI) is used as a starting material in the preparation of various organic compounds, contributing to the synthesis of a wide range of chemical products.
Used in Anticancer Drug Development:
3-Pyridinecarboxylic acid, 4-methyl, hydrazide (9CI) has been researched for its potential application in the development of anticancer drugs, making it a promising candidate for further investigation and development in the field of oncology.
Used in Heterocyclic Compound Synthesis:
3-Pyridinecarboxylic acid, 4-methyl, hydrazide (9CI) serves as a precursor in the synthesis of heterocyclic compounds, which are important in various chemical and pharmaceutical applications.
Check Digit Verification of cas no
The CAS Registry Mumber 6316-67-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,3,1 and 6 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 6316-67:
(6*6)+(5*3)+(4*1)+(3*6)+(2*6)+(1*7)=92
92 % 10 = 2
So 6316-67-2 is a valid CAS Registry Number.
InChI:InChI=1/C7H9N3O/c1-5-2-3-9-4-6(5)7(11)10-8/h2-4H,8H2,1H3,(H,10,11)
6316-67-2Relevant academic research and scientific papers
TRIAZOLE AGONISTS OF THE APJ RECEPTOR
-
Paragraph 0322; 0323, (2016/12/07)
Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures where the definitions of the variables are provided herein.
Pyrido[4,3- e ][1,2,4]triazolo[4,3- a ]pyrazines as selective, brain penetrant phosphodiesterase 2 (PDE2) inhibitors
Rombouts, Frederik J. R.,Tresadern, Gary,Buijnsters, Peter,Langlois, Xavier,Tovar, Fulgencio,Steinbrecher, Thomas B.,Vanhoof, Greet,Somers, Marijke,Andrés, José-Ignacio,Trabanco, Andrés A.
supporting information, p. 282 - 286 (2015/03/30)
A novel series of pyrido[4,3-e][1,2,4]triazolo[4,3-a]pyrazines is reported as potent PDE2/PDE10 inhibitors with drug-like properties. Selectivity for PDE2 was obtained by introducing a linear, lipophilic moiety on the meta-position of the phenyl ring pending from the triazole. The SAR and protein flexibility were explored with free energy perturbation calculations. Rat pharmacokinetic data and in vivo receptor occupancy data are given for two representative compounds 6 and 12.
Inhibitors of VEGF receptors-1 and -2 based on the 2-((pyridin-4-yl)ethyl) pyridine template
Kiselyov, Alexander S.,Semenova, Marina,Semenov, Victor V.,Milligan, Daniel
, p. 1913 - 1919 (2007/10/03)
We have developed a series of novel potent ((pyridin-4-yl)ethyl)pyridine derivatives active against kinases VEGFR-1 and -2. Both specific and dual ATP-competitive inhibitors of VEGFR-2 were identified. Kinase selectivity could be controlled by varying the
